- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | NT PHARMA (01011): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 28 AUGUST 2026 | 5 | HKEx | ||
| 20.08. | NT PHARMA (01011): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 2 | HKEx | ||
| 19.08. | NT PHARMA Ordered to Pay About RMB92 Million in Penalties and Other Fees; Initiates Legal Procedures to Set Aside Arbitration Award | 1 | AASTOCKS | ||
| 18.08. | NT PHARMA (01011): INSIDE INFORMATION ANNOUNCEMENT ARBITRATION AWARD | 1 | HKEx | ||
| CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
| 10.08. | NT PHARMA (01011): DATE OF BOARD MEETING | 1 | HKEx | ||
| 10.08. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | 1 | HKEx | ||
| 10.08. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | 5 | HKEx | ||
| 10.08. | NT PHARMA (01011): FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING | 3 | HKEx | ||
| 10.08. | NT PHARMA (01011): NOTICE OF EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 10.08. | NT PHARMA (01011): CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE, APPOINTMENT OF AUDITOR ... | 2 | HKEx | ||
| 31.07. | NT PHARMA (01011): QUARTERLY UPDATES ON THE IMPLEMENTATION OF ACTION PLANS TO RESOLVE THE DISCLAIMER OF OPINION | 2 | HKEx | ||
| 31.07. | NT PHARMA (01011): FURTHER DELAY IN DESPATCH OF CIRCULAR | 3 | HKEx | ||
| 10.07. | NT PHARMA (01011): DELAY IN DESPATCH OF CIRCULAR | - | HKEx | ||
| 07.07. | NT PHARMA (01011): APPOINTMENT OF AUDITOR | - | HKEx | ||
| 03.07. | NT PHARMA (01011): UPDATE ON IMPLEMENTATION OF REMEDIAL ACTIONS AND KEY FINDINGS OF INTERNAL CONTROL REVIEW | 1 | HKEx | ||
| 03.07. | NT PHARMA (01011): CHANGE OF CHIEF EXECUTIVE OFFICER | 2 | HKEx | ||
| 17.06. | NT PHARMA (01011): CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE | 1 | HKEx | ||
| 12.06. | NT PHARMA (01011): SUPPLEMENTAL ANNOUNCEMENT RETIREMENT OF AUDITOR | 1 | HKEx | ||
| 04.06. | NT PHARMA (01011): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 4 JUNE 2026 AND RETIREMENT OF AUDITOR | 1 | HKEx | ||
| 29.05. | NT PHARMA (01011): VOLUNTARY ANNOUNCEMENT IN RELATION TO THE PROPOSED DISPOSAL OF THE EQUITY INTERESTS IN NT PHARMA (OVERSEAS) HOLDING CO., LTD | - | HKEx |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,454 | -0,12 % | Aurora Cannabis: Was Curaleaf jetzt wirklich plant | ||
| CANOPY GROWTH | 0,866 | +1,05 % | Canopy Growth Corporation: Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows | Renewed certification maintains Kincardine's role in Canopy Growth's EU GMP flower supply chain
Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX: WEED) (Nasdaq: CGC)... ► Artikel lesen | |
| TILRAY BRANDS | 3,980 | +0,51 % | Tilray Brands, Inc.: BrewDog triumphiert bei den World Beer Awards 2026 mit herausragender Braukunst | Hazy Jane, Wingman und Mackie's Two Scoops werden mit Goldmedaillen und dem Scotland Country Winner Award ausgezeichnet. Zu den besten Bieren der Welt zählen auch Punk IPA, Lost Lager, Black Heart und... ► Artikel lesen | |
| DIGICANN VENTURES | 0,007 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SINOPHARM | 1,760 | +0,74 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE SIX MONTHS ENDED 30 JUNE 2026 | ||
| CSPC PHARMA | 1,090 | +1,45 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR ... | ||
| ORAMED PHARMACEUTICALS | 4,430 | +1,96 % | Oramed Pharmaceuticals Inc.: Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet | Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million)
Scilex (NASDAQ: SCLX) Loan Substantially Repaid
Total Cash and Assets Build... ► Artikel lesen | |
| ADASTRA | 0,127 | +2,42 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| METRIOPHARM | - | - | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
-- Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of
MetrioPharm... ► Artikel lesen | |
| BAYER | 48,670 | +0,39 % | Bayer-Aktie: Score 1 - Warum das Rekordurteil nichts ändert - Warren Wise Podcast | Ein Risiko weniger ist noch keine Rendite: Der Oberste US-Gerichtshof hat im langen Glyphosat-Streit zugunsten von Bayer entschieden. Die Aktie sprang daraufhin deutlich nach oben. Trotzdem steht Bayer... ► Artikel lesen | |
| MERCK KGAA | 140,25 | +0,11 % | Milliardenmarkt Krebs: Moderna und Merck läuten die nächste Biotech-Ära ein | Ein Durchbruch in der Krebsforschung sorgt für Euphorie an der Börse. Moderna und Merck feiern einen Studienerfolg. Jetzt hoffen Anleger auf die nächste große Biotech-Rallye und neue Milliardenmärkte.... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 59,78 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| NOVO NORDISK | 39,405 | +0,04 % | BioTech: Übernahmen! Der Kampf um Marktanteile bei Novo Nordisk und Eli Lilly, BioNxt und Evotec auf dem M&A-Radar | Wie die jüngste, spektakuläre 43-Milliarden-USD-Übernahme des Krebsspezialisten Seagen durch Pfizer oder die Mega-Deals rund um die GLP-1-Infrastruktur eindrucksvoll zeigen, befindet sich die Pharmabranche... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 15,310 | -0,13 % | Generate Biomedicines stock price target raised to $30 by H.C. Wainwright on asthma data |
CHINA NT PHARMA GROUP CO LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA NT PHARMA GROUP CO LTD finden Sie auf Wallstreet Online.